Skip to content
  • The Charities
  • Start fundraising now
  • Super Rare Events
  • For schools
  • Rare Voices Report
    • Commitments
    • Recommendations
  • Get Support
    • Get Support
    • Contact Us
    • Podcast
    • Videos
  • The Charities
  • Start fundraising now
  • Super Rare Events
  • For schools
  • Rare Voices Report
    • Commitments
    • Recommendations
  • Get Support
    • Get Support
    • Contact Us
    • Podcast
    • Videos
  • The Charities
  • Start fundraising now
  • Super Rare Events
  • For schools
  • Rare Voices Report
    • Commitments
    • Recommendations
  • Get Support
    • Get Support
    • Contact Us
    • Podcast
    • Videos
  • The Charities
  • Start fundraising now
  • Super Rare Events
  • For schools
  • Rare Voices Report
    • Commitments
    • Recommendations
  • Get Support
    • Get Support
    • Contact Us
    • Podcast
    • Videos

Rare Voices Report

At the start of this year, our alliance of charities concluded our National Community Survey into the experiences of those with rare conditions affecting the bone marrow.

Since then, we have been working together to publish our findings as a comprehensive report, which provides a new and detailed insight into the experiences of living with a rare bone marrow condition. 

To read the report select an option below.

 

Report format
We will only use this information for the purpose of sending you the report.

WITH THANKS TO

The report was funded thanks to sponsorship from Alexion AstraZeneca Rare Disease, Pfizer, Roche and Sobi, and the survey was funded by sponsorship from Alexion AstraZeneca Rare Disease, Roche and Sobi. The survey development was supported by Absolute Market Research and M+F Health, and the report development was supported by M+F Health.  

Alexion AstraZeneca Rare Disease, Pfizer, Roche and Sobi had no editorial control over the content of the report.

Super Rare is supported by The National Lottery Community Fund – thanks to players of The National Lottery.
Super Rare – But not alone

All rights reserved